Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M adjuvant, participated in U.S. Food and Drug Administration (FDA) Vaccines and Related...
New research in the June 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network found that when alectinib—a safe and effective small molecule kinase inhibitor used to...
As international demand for starting substances for use in cell therapy emerges, California-based regenerative therapeutics company StemCyte announced it has signed a cooperation agreement with...
IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced selection of a monotherapy expansion dose...
HanAll Biopharma and Daewoong Pharmaceutical announced the expansion of their open collaboration strategy by investing in Vincere Biosciences, a Cambridge, MA-based company developing therapeutics...
